Literature DB >> 16135620

Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.

James J McGough1, Susan L Smalley, James T McCracken, May Yang, Melissa Del'Homme, Deborah E Lynn, Sandra Loo.   

Abstract

OBJECTIVE: Patterns of psychiatric comorbidity were assessed in adults with and without attention deficit hyperactivity disorder (ADHD) identified through a genetic study of families containing multiple children with ADHD.
METHOD: Lifetime ADHD and comorbid psychopathology were assessed in 435 parents of children with ADHD. Rates and mean ages at onset of comorbid psychopathology were compared in parents with lifetime ADHD, parents with persistent ADHD, and those without ADHD. Age-adjusted rates of comorbidity were compared with Kaplan-Meier survival curves. Logistic regression was used to assess additional risk factors for conditions more frequent in ADHD subjects.
RESULTS: The parents with ADHD were significantly more likely to be unskilled workers and less likely to have a college degree. ADHD subjects had more lifetime psychopathology; 87% had at least one and 56% had at least two other psychiatric disorders, compared with 64% and 27%, respectively, in non-ADHD subjects. ADHD was associated with greater disruptive behavior, substance use, and mood and anxiety disorders and with earlier onset of major depression, dysthymia, oppositional defiant disorder, and conduct disorder. Group differences based on Kaplan-Meier age-corrected risks were consistent with those for raw frequency distributions. Male sex added risk for disruptive behavior disorders. Female sex and oppositional defiant disorder contributed to risk for depression and anxiety. ADHD was not a significant risk factor for substance use disorders when male sex, disruptive behavior disorders, and socioeconomic status were controlled.
CONCLUSIONS: Adult ADHD is associated with significant lifetime psychiatric comorbidity that is not explained by clinical referral bias.

Entities:  

Mesh:

Year:  2005        PMID: 16135620     DOI: 10.1176/appi.ajp.162.9.1621

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  72 in total

1.  Increased symptoms of attention deficit hyperactivity disorder and major depressive disorder symptoms in Nail-patella syndrome: potential association with LMX1B loss-of-function.

Authors:  Carmen López-Arvizu; Elizabeth P Sparrow; Michael J Strube; Chris Slavin; Caroline DeOleo; Justin James; Julie Hoover-Fong; Iain McIntosh; Elaine Tierney
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-02       Impact factor: 3.568

2.  Treating comorbid ADHD in adults: mixed results in recent clinical trials.

Authors:  Anthony L Rostain
Journal:  Curr Psychiatry Rep       Date:  2006-10       Impact factor: 5.285

3.  Managing ADHD in children, adolescents, and adults with comorbid anxiety in primary care.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

4.  Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder.

Authors:  Ake T Lu; Matthew N Ogdie; Marjo-Ritta Järvelin; Irma K Moilanen; Sandra K Loo; James T McCracken; James J McGough; May H Yang; Leena Peltonen; Stanley F Nelson; Rita M Cantor; Susan L Smalley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

5.  Dose of Methylphenidate during Service Transition for Adults with ADHD.

Authors:  Marios Adamou; Sara Bowers
Journal:  Ther Adv Psychopharmacol       Date:  2011-06

6.  A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD.

Authors:  Earle E Bain; Weining Robieson; Yili Pritchett; Tushar Garimella; Walid Abi-Saab; George Apostol; James J McGough; Mario D Saltarelli
Journal:  Neuropsychopharmacology       Date:  2012-10-03       Impact factor: 7.853

7.  Familial transmission of derived phenotypes for molecular genetic studies of substance use disorders.

Authors:  Stephen V Faraone; Joel J Adamson; Timothy E Wilens; Michael C Monuteaux; Joseph Biederman
Journal:  Drug Alcohol Depend       Date:  2007-09-04       Impact factor: 4.492

8.  Perinatal Outcomes of Women Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Australian Population-Based Cohort Study.

Authors:  Alison S Poulton; Bruce Armstrong; Ralph K Nanan
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

Review 9.  ADHD is associated with migraine: a systematic review and meta-analysis.

Authors:  Haitham Salem; David Vivas; Fei Cao; Iram F Kazimi; Antonio L Teixeira; Cristian P Zeni
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-09-13       Impact factor: 4.785

Review 10.  Genetic aspects in attention-deficit/hyperactivity disorder.

Authors:  O Albayrak; S Friedel; B G Schimmelmann; A Hinney; J Hebebrand
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.